FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人:
DE VIVO, MARCO,GANESAN, ANAND,ORTEGA MARTINEZ, JOSE ANTONIO,JAHID, SOHAIL
申请号：
CA3062260
公开号：
CA3062260A1
申请日:
2018.05.02
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: It further discloses a pharmaceutical composition comprising the compounds of Formula (I) and their uses, in particular in the treatment of diseases or disorders associated to increased relative to physiological or desired RhoJ/Cdc42 levels of expression or function.
